VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH 2017 | Promising results for venetoclax combination therapies in elderly AML

In this exciting interview, Marina Konopleva, MD, PhD of the MD Anderson Cancer Center, Houston, TX, provides optimistic preliminary results from clinical trials (NCT02287233 and NCT02203773) utilizing venetoclax in elderly acute myeloid leukemia (AML) patients. Thus, Dr Konopleva is hopeful for the approval of venetoclax in combination therapies for AML. This video was recorded at the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter